A placebo-controlled trial of a proprietary lipid-lowering nutraceutical supplement in the management of dyslipidemia.

M. Houston,R. Rountree,J. Lamb,S. Phipps,S. Meng,B. Zhang
DOI: https://doi.org/10.1016/j.jacl.2016.03.072
2016-05-01
Journal of biological regulators and homeostatic agents
Abstract:
What problem does this paper attempt to address?